I-Mab Current Ratio 2020-2019 | IMAB

I-Mab current ratio from 2020 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
I-Mab Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-12-31 $0.20B $0.05B 4.12
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.321B $0.004B
I-Mab is a clinical stage biopharmaceutical company. It engages in discovery, development and commercialization of biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab is based in SHANGHAI, China.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $136.056B 10.48
Amgen (AMGN) United States $133.046B 14.45
CSL (CSLLY) Australia $96.162B 0.00
Gilead Sciences (GILD) United States $76.214B 10.97
Regeneron Pharmaceuticals (REGN) United States $61.687B 23.59
Vertex Pharmaceuticals (VRTX) United States $55.110B 30.75
Illumina (ILMN) United States $47.238B 54.93
Biogen (BIIB) United States $40.779B 7.24
Seattle Genetics (SGEN) United States $34.263B 0.00
Moderna (MRNA) United States $27.830B 0.00
BeiGene (BGNE) Cayman Islands $27.099B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.654B 11.11
Genmab (GMAB) Denmark $23.363B 14.74
Genmab (GNMSF) Denmark $21.483B 4.95
Immunomedics (IMMU) United States $20.308B 0.00
BioNTech SE (BNTX) Germany $20.067B 0.00
Incyte (INCY) United States $19.615B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.779B 0.00
Bio-Rad Laboratories (BIO.B) United States $17.079B 77.25
Exact Sciences (EXAS) United States $16.473B 0.00
Horizon Therapeutics Public (HZNP) Ireland $15.988B 37.41
Alnylam Pharmaceuticals (ALNY) United States $15.289B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.060B 102.01
MyoKardia (MYOK) United States $11.818B 0.00
ARGENX SE-ADR (ARGX) Netherlands $11.772B 0.00
QIAGEN (QGEN) Netherlands $11.344B 28.79
Sarepta Therapeutics (SRPT) United States $10.813B 0.00
Guardant Health (GH) United States $10.411B 0.00
Bio-Techne Corp (TECH) United States $10.351B 71.02
Repligen (RGEN) United States $9.254B 146.88
Ascendis Pharma (ASND) Denmark $8.442B 0.00
Galapagos (GLPG) Belgium $8.341B 30.18
Mirati Therapeutics (MRTX) United States $8.026B 0.00
Exelixis (EXEL) United States $6.888B 25.05
ACADIA Pharmaceuticals (ACAD) United States $6.807B 0.00
Adaptive Biotechnologies (ADPT) United States $6.722B 0.00
Acceleron Pharma (XLRN) United States $6.549B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $6.501B 201.41
Blueprint Medicines (BPMC) United States $5.785B 0.00
Novavax (NVAX) United States $5.707B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.638B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.355B 14.63
Emergent Biosolutions (EBS) United States $5.087B 20.15
Amicus Therapeutics (FOLD) United States $4.782B 0.00
Arena Pharmaceuticals (ARNA) United States $4.689B 0.00
NeoGenomics (NEO) United States $4.565B 1378.00
China Biologic Products (CBPO) China $4.455B 26.44
Vir Biotechnology (VIR) United States $4.410B 0.00
Denali Therapeutics (DNLI) United States $4.360B 0.00
Halozyme Therapeutics (HALO) United States $4.262B 0.00
Fate Therapeutics (FATE) United States $4.200B 0.00
Reata Pharmaceuticals (RETA) United States $3.941B 0.00
Twist Bioscience (TWST) United States $3.840B 0.00
Insmed (INSM) United States $3.754B 0.00
Bluebird Bio (BLUE) United States $3.677B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.612B 0.00
Legend Biotech (LEGN) United States $3.570B 0.00
Global Blood Therapeutics (GBT) United States $3.458B 0.00
MorphoSys AG (MOR) Germany $3.451B 45.22
Eidos Therapeutics (EIDX) United States $2.827B 0.00
Alkermes (ALKS) Ireland $2.607B 54.63
Seres Therapeutics (MCRB) United States $2.300B 0.00
PHARMA MAR SA (PHMMF) Spain $2.294B 0.00
Sorrento Therapeutics (SRNE) United States $2.115B 0.00
Editas Medicine (EDIT) United States $2.040B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.991B 0.00
Beam Therapeutics (BEAM) United States $1.960B 0.00
Amarin (AMRN) Ireland $1.947B 0.00
UniQure (QURE) Netherlands $1.895B 0.00
Zymeworks (ZYME) Canada $1.870B 0.00
Inovio Pharmaceuticals (INO) United States $1.834B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.817B 20.35
Viela Bio (VIE) United States $1.792B 0.00
Intra-Cellular Therapies (ITCI) United States $1.757B 0.00
Revance Therapeutics (RVNC) United States $1.667B 0.00
Northwest Biotherapeutics (NWBO) United States $1.585B 0.00
Sangamo Therapeutics (SGMO) United States $1.528B 0.00
Zealand Pharma (ZLDPF) Denmark $1.483B 0.00
Zealand Pharma (ZEAL) Denmark $1.481B 0.00
Intellia Therapeutics (NTLA) United States $1.461B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.444B 0.00
Ligand Pharmaceuticals (LGND) United States $1.367B 46.21
Epizyme (EPZM) United States $1.352B 0.00
Mesoblast (MESO) Australia $1.315B 0.00
Arcus Biosciences (RCUS) United States $1.307B 0.00
Mersana Therapeutics (MRSN) United States $1.264B 0.00
Coherus BioSciences (CHRS) United States $1.257B 7.33
Alcobra (ARCT) United States $1.208B 0.00
NGM Biopharmaceuticals (NGM) United States $1.174B 0.00
Cytokineticsorporated (CYTK) United States $1.156B 0.00
Heska (HSKA) United States $1.137B 0.00
Myriad Genetics (MYGN) United States $1.099B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.091B 0.00
REGENXBIO (RGNX) United States $1.077B 0.00
Retrophin (RTRX) United States $1.066B 0.00
Castle Biosciences (CSTL) United States $1.020B 0.00
Genetron Holdings (GTH) China $1.004B 0.00
Adverum Biotechnologies (ADVM) United States $0.997B 0.00
Compugen (CGEN) Israel $0.969B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.966B 0.00
Vericel (VCEL) United States $0.939B 0.00
Athenex (ATNX) United States $0.936B 0.00
NantKwest (NK) United States $0.926B 0.00
Morphic Holding (MORF) United States $0.879B 0.00
Codexis (CDXS) United States $0.852B 0.00
Pliant Therapeutics (PLRX) United States $0.843B 0.00
Arvinas (ARVN) United States $0.826B 0.00
Cellectis S.A (CLLS) France $0.825B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.813B 0.00
Intrexon (PGEN) United States $0.784B 0.00
Alector (ALEC) United States $0.752B 0.00
Frequency Therapeutics (FREQ) United States $0.739B 0.00
Protagonist Therapeutics (PTGX) United States $0.734B 0.00
Agenus (AGEN) United States $0.723B 0.00
AnaptysBio (ANAB) United States $0.703B 0.00
Pharming Group (PHGUF) Netherlands $0.682B 15.57
Cara Therapeutics (CARA) United States $0.669B 0.00
MiMedx (MDXG) United States $0.651B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Celldex Therapeutics (CLDX) United States $0.639B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.625B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.617B 0.00
Kadmon Holdings (KDMN) United States $0.604B 0.00
VBI Vaccines (VBIV) United States $0.590B 0.00
Geron (GERN) United States $0.587B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.580B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.560B 4.90
Autolus Therapeutics (AUTL) United Kingdom $0.540B 0.00
IVERIC Bio (ISEE) United States $0.537B 0.00
Albireo Pharma (ALBO) United States $0.522B 0.00
Anika Therapeutics (ANIK) United States $0.500B 21.87
MeiraGTx Holdings (MGTX) United States $0.498B 0.00
Clovis Oncology (CLVS) United States $0.492B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.486B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.478B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.472B 0.00
MannKind (MNKD) United States $0.470B 0.00
Avid Bioservices (CDMO) United States $0.464B 0.00
Prothena (PRTA) Ireland $0.457B 0.00
Dynavax Technologies (DVAX) United States $0.456B 0.00
UROGEN PHARMA (URGN) United States $0.447B 0.00
Sutro Biopharma (STRO) United States $0.441B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.440B 0.00
Amryt Pharma (AMYT) United Kingdom $0.438B 0.00
Kala Pharmaceuticals (KALA) United States $0.434B 0.00
Scholar Rock Holding (SRRK) United States $0.422B 0.00
Starpharma Holdings (SPHRY) Australia $0.419B 0.00
Forte Biosciences (FBRX) United States $0.387B 0.00
Merus (MRUS) Netherlands $0.379B 0.00
Puma Biotechnology (PBYI) United States $0.377B 0.00
Cue Biopharma (CUE) United States $0.377B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.375B 0.00
Kamada (KMDA) Israel $0.373B 17.83
Innate Pharma S.A (IPHA) France $0.369B 0.00
Precision BioSciences (DTIL) United States $0.365B 0.00
Spero Therapeutics (SPRO) United States $0.362B 0.00
AC Immune SA (ACIU) Switzerland $0.358B 0.00
Cellular Biomedicine (CBMG) United States $0.358B 0.00
ANI Pharmaceuticals (ANIP) United States $0.357B 8.42
Trevena (TRVN) United States $0.350B 0.00
Syros Pharmaceuticals (SYRS) United States $0.345B 0.00
BioDelivery Sciences (BDSI) United States $0.343B 24.29
Aeglea BioTherapeutics (AGLE) United States $0.343B 0.00
NextCure (NXTC) United States $0.342B 0.00
Cardiff Oncology (CRDF) United States $0.337B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.336B 0.00
Athersys (ATHX) United States $0.318B 0.00
CytomX Therapeutics (CTMX) United States $0.312B 0.00
Osmotica Pharmaceuticals (OSMT) United States $0.306B 0.00
Selecta Biosciences (SELB) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.297B 0.00
WAVE Life Sciences (WVE) Singapore $0.291B 0.00
PDL BioPharma (PDLI) United States $0.258B 0.00
Pluristem Therapeutics (PSTI) Israel $0.252B 0.00
Affimed (AFMD) Germany $0.252B 0.00
XOMA (XOMA) United States $0.249B 0.00
TELA Bio (TELA) United States $0.245B 0.00
Arbutus Biopharma (ABUS) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.233B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.225B 0.00
Dyadic (DYAI) United States $0.214B 0.00
HOOKIPA Pharma (HOOK) United States $0.210B 0.00
Verastem (VSTM) United States $0.207B 0.00
Five Prime Therapeutics (FPRX) United States $0.204B 0.00
ADMA Biologics Inc (ADMA) United States $0.194B 0.00
POXEL SA FRANCE (PXXLF) France $0.185B 0.00
Eton Pharmaceuticals (ETON) United States $0.185B 0.00
Cerecor (CERC) United States $0.174B 0.00
Liquidia Technologies (LQDA) United States $0.172B 0.00
GENFIT S.A (GNFT) France $0.169B 0.00
DBV Technologies S.A (DBVT) France $0.168B 0.00
Biofrontera AG (BFRA) Germany $0.167B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.167B 0.00
Kindred Biosciences (KIN) United States $0.160B 0.00
Theratechnologies (THTX) Canada $0.158B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.152B 0.00
Nicox SA (NICXF) France $0.149B 0.00
Bellus Health (BLU) Canada $0.148B 0.00
Aptinyx (APTX) United States $0.147B 0.00
Checkpoint Therapeutics (CKPT) United States $0.147B 0.00
Exicure (XCUR) United States $0.146B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.142B 6.65
Applied Genetic Technologies (AGTC) United States $0.141B 0.00
SESEN BIO, INC (SESN) United States $0.138B 0.00
AquaBounty Technologies (AQB) United States $0.138B 0.00
Prometic Life Sciences (LMNL) Canada $0.135B 0.00
Cidara Therapeutics (CDTX) United States $0.130B 0.00
Aytu Bioscience (AYTU) United States $0.125B 0.00
Catalyst Biosciences (CBIO) United States $0.121B 0.00
Lumos Pharma (LUMO) United States $0.119B 0.00
Unum Therapeutics (COGT) United States $0.118B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.118B 0.00
VTv Therapeutics (VTVT) United States $0.117B 0.00
Strongbridge Biopharma (SBBP) United States $0.114B 0.00
Gritstone Oncology (GRTS) United States $0.114B 0.00
Abeona Therapeutics (ABEO) United States $0.114B 0.00
Windtree Therapeutics (WINT) United States $0.113B 0.00
Celyad SA (CYAD) Belgium $0.113B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Orgenesis (ORGS) United States $0.110B 5.61
Antibe Therapeutics (ATBPF) Canada $0.103B 0.00
AIT Therapeutics (XAIR) United States $0.102B 0.00
Oncobiologics (OTLK) United States $0.102B 0.00
Enzo Biochem (ENZ) United States $0.101B 0.00
PhaseBio Pharaceuticals (PHAS) United States $0.091B 0.00
Cyclerion Therapeutics (CYCN) United States $0.090B 0.00
Ecology Coatings (ABVC) United States $0.085B 0.00
ARAVIVE, INC (ARAV) United States $0.084B 0.00
Evogene (EVGN) Israel $0.082B 0.00
DiaMedica Therapeutics (DMAC) United States $0.081B 0.00
Idera Pharmaceuticals (IDRA) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) United States $0.074B 71.39
Bionano Genomics (BNGO) United States $0.074B 0.00
Prima BioMed (IMMP) Australia $0.070B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.069B 0.00
Synlogic (SYBX) United States $0.068B 0.00
Organovo Holdings (ONVO) United States $0.068B 0.00
Adocia (ADOCY) France $0.067B 0.00
Clearside Biomedical (CLSD) United States $0.065B 0.00
Appili Therapeutics (APLIF) Canada $0.064B 0.00
Curis (CRIS) United States $0.062B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.061B 0.00
Edesa Biotech (EDSA) Canada $0.060B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.059B 0.00
Proteostasis Therapeutics (PTI) United States $0.058B 0.00
TRACON Pharmaceuticals (TCON) United States $0.058B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.056B 0.00
Soligenix (SNGX) United States $0.054B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.054B 0.00
Vascular Biogenics (VBLT) Israel $0.049B 0.00
Genetic Technologies (GENE) Australia $0.046B 0.00
Cocrystal Pharma (COCP) United States $0.045B 0.00
Happiness Biotech Group (HAPP) China $0.044B 0.00
Novogen (KZIA) Australia $0.043B 0.00
IMMURON (IMRN) Australia $0.041B 0.00
AnPac Bio-Medical Science (ANPC) China $0.040B 0.00
Acorda Therapeutics (ACOR) United States $0.040B 0.00
CollPlant Holdings (CLGN) Israel $0.040B 0.00
Chanticleer Holdings (SONN) United States $0.039B 0.00
Pulmatrix (PULM) United States $0.039B 0.00
Vaccinex (VCNX) United States $0.038B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
Cleveland BioLabs (CBLI) United States $0.034B 0.00
OvaScience (MLND) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
ATyr Pharma (LIFE) United States $0.033B 0.00
Signal Genetics (MGEN) United States $0.028B 0.00
BioCardia (BCDA) United States $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.026B 0.00
Prana Biotechnology (ATHE) Australia $0.024B 0.00
Alimera Sciences (ALIM) United States $0.023B 0.00
Aptevo Therapeutics (APVO) United States $0.023B 0.00
Spherix (AIKI) United States $0.020B 0.00
Celsion (CLSN) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.019B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
Cesca Therapeutics (THMO) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Titan Pharmaceuticals (TTNP) United States $0.013B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.003B 0.00
GeoVax Labs (GOVX) United States $0.002B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00
Zai Lab (ZLAB) China $0.000B 0.00